Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients

Carcinogenesis

Volumn 32, Issue 5, 2011, Pages 741-747

  Rawson, James B ^a,b   Manno, Michael ^c   Mrkonjic, Miralem ^a,b   Daftary, Darshana ^c   Dicks, Elizabeth ^d   Buchanan, Daniel D ^e   Younghusband, H Banfield ^d   Parfrey, Patrick S ^d   Young, Joanne P ^e   Pollett, Aaron ^b   Green, Roger C ^d   Gallinger, Steven ^a,b,c   McLaughlin, John R ^b,c,f   Knight, Julia A ^b,f   Bapat, Bharati ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c CANCER CARE ONTARIO   (Canada)

^d MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DICKKOPF 1 PROTEIN; SECRETED FRIZZLED RELATED PROTEIN 1;

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHYLATION; MICROSATELLITE INSTABILITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

EID: 79955773267     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr020     Document Type: Article

References (52)

1. Marrett,L.D. et al. (2008) Cancer in Canada in 2008. CMAJ, 179, 1163-1170.
2. Altekruse,S. et al. (2007) SEER Cancer Statistics Review, 1975-2007. National Cancer Institute, Bethesda, MD.
3. Campbell,P.T. et al. (2010) Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst, 102, 391-400.
4. Carethers,J.M. et al. (2004) Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology, 126, 394-401.
5. Ribic,C.M. et al. (2003) Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med, 349, 247-257.
6. Weisenberger,D.J. et al. (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet, 38, 787-793.
7. Barker,N. et al. (2006) Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov, 5, 997-1014.
8. Kikuchi,A. et al. (2008) Tumor formation due to abnormalities in the beta-catenin-independent pathway of Wnt signaling. Cancer Sci, 99, 202-208.
9. Wang,Y. (2009) Wnt/planar cell polarity signaling: a new paradigm for cancer therapy. Mol Cancer Ther, 8, 2103-2109.
10. Sato,H. et al. (2007) Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis, 28, 2459-2466.
11. Suzuki,H. et al. (2004) Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet, 36, 417-422.
12. Aguilera,O. et al. (2006) Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene, 25, 4116-4121.
13. Suzuki,H. et al. (2008) Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer, 98, 1147-1156.
14. Maehata,T. et al. (2008) Transcriptional silencing of Dickkopf gene family by CpG island hypermethylation in human gastrointestinal cancer. World J Gastroenterol, 14, 2702-2714.
15. Takagi,H. et al. (2008) Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma. J Gastroenterol, 43, 378-389.
16. Zou,H. et al. (2005) Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer, 116, 584-591.
17. Lee,A.Y. et al. (2004) Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene, 23, 6672-6676.
18. Jost,E. et al. (2009) Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma. Cancer Lett, 281, 24-31.
19. Valencia,A. et al. (2009) Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia. Leukemia, 23, 1658-1666.
20. Urakami,S. et al. (2006) Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin Cancer Res, 12, 6989-6997.
21. Jost,E. et al. (2008) Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia. Br J Haematol, 142, 745-753.
22. Veeck,J. et al. (2009) Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer. BMC Cancer, 9, 217.
23. Veeck,J. et al. (2008) Epigenetic inactivation of the secreted frizzledrelated protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis. Carcinogenesis, 29, 991-998.
24. Suzuki,M. et al. (2009) Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling. Ann Surg Oncol, 17, 878-888.
25. Suzuki,M. et al. (2007) Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non small cell lung cancer. Clin Cancer Res, 13, 6087-6092.
26. Qi,J. et al. (2006) Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World J Gastroenterol, 12, 7113-7117.
27. Woods,M.O. et al. (2005) High frequency of hereditary colorectal cancer in Newfoundland likely involves novel susceptibility genes. Clin Cancer Res, 11, 6853-6861.
28. Suzuki,H. et al. (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet, 31, 141-149.
29. Newcomb,P.A. et al. (2007) Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev, 16, 2331-2343.
30. Raptis,S. et al. (2007) MLH1-93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. J Natl Cancer Inst, 99, 463-474.
31. Green,R.C. et al. (2007) Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other populationbased studies. Fam Cancer, 6, 53-62.
32. Walsh,M.D. et al. (2010) Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res, 16, 2214-2224.
33. Loughrey,M.B. et al. (2007) Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Fam Cancer, 6, 301-310.
34. Lindor,N.M. et al. (2002) Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol, 20, 1043-1048.
35. Eads,C.A. et al. (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res, 28, E32.
36. Weisenberger,D.J. et al. (2005) Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res, 33, 6823-6836.
37. Ogino,S. et al. (2006) Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn, 8, 209-217.
38. An,B. et al. (2010) A characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers. Int J Cancer, 127, 2095-2105.
39. Konishi,K. et al. (2007) Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. Gastroenterology, 132, 1254-1260.
40. Ogino,S. et al. (2008) Molecular classification and correlates in colorectal cancer. J Mol Diagn, 10, 13-27.
41. Ogino,S. et al. (2009) CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut, 58, 90-96.
42. Dahlin,A.M. et al. (2010) The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status. Clin Cancer Res, 16, 1845-1855.
43. Risinger,J.I. et al. (2005) Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling. Cancer Res, 65, 5031-5037.
44. Bovolenta,P. et al. (2008) Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J Cell Sci, 121, 737-746.
45. Niehrs,C. (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene, 25, 7469-7481.
46. Albuquerque,C. et al. (2010) Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability. Genes Chromosomes Cancer, 49, 746-759.
47. Ortega,P. et al. (2008) Differential Wnt pathway gene expression and Ecadherin truncation in sporadic colorectal cancers with and without microsatellite instability. Clin Cancer Res, 14, 995-1001.
48. Thorstensen,L. et al. (2005) Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. Neoplasia, 7, 99-108.
49. Ueno,K. et al. (2009) Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. Br J Cancer, 101, 1374-1381.
50. Zhao,Y. et al. (2010) Dishevelled-1 and dishevelled-3 affect cell invasion mainly through canonical and noncanonical Wnt pathway, respectively, and associate with poor prognosis in nonsmall cell lung cancer. Mol Carcinog, 49, 760-770.
51. Filho,L. et al. (2009) Canonical and noncanonical Wnt pathway: a comparison among normal ovary, benign ovarian tumor and ovarian cancer. Oncology Reports, 21, 313-320.
52. Yamamoto,H. et al. (2010) Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene, 29, 2036-2046.